Stock Events

Stock Events

Harrow 

$40.95
104
-$1.11-2.64% Friday 20:00
+$0.00+0%Friday 23:30After hours

Statistics

Day High
41.03
Day Low
40.93
52W High
54.85
52W Low
28.54
Volume
8,149
Avg. Volume
-
Mkt Cap
1.54B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

16NovExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.74
-0.42
-0.1
0.22
Expected EPS
0.218775
Actual EPS
N/A

Financials

-1.89%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
272.3MRevenue
-5.14MNet Income

Analyst Ratings

71.50Average Price Target
The highest estimate is 88.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HROW. It's not an investment recommendation.
NVIDIA
24
NVDA
Amazon
23
AMZN
Nebius Group N.V.
23
NBIS
Palantir Technologies
22
PLTR

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Novartis
NVS
Mkt Cap286.78B
Novartis, through its Alcon division, is a leading company in eye care, offering products that compete with Harrow's treatments and solutions for eye health.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie, having acquired Allergan, competes in various therapeutic areas including ophthalmology, making it a direct competitor to Harrow in the eye care market.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its Vision Care division, offers products for eye health, including contact lenses and surgical products, competing with Harrow.
Pfizer
PFE
Mkt Cap152.69B
Pfizer has a diverse range of healthcare products, including treatments in ophthalmology, which puts it in competition with Harrow in the eye care market.
Regenxbio
RGNX
Mkt Cap710.63M
REGENXBIO Inc. is involved in the development of gene therapy products, including treatments for eye diseases, making it a competitor in the specialized segment of eye care.
Bausch Health Companies
BHC
Mkt Cap2.43B
Bausch Health Companies, formerly Valeant Pharmaceuticals, has a significant presence in eye health through its Bausch + Lomb segment, directly competing with Harrow.
National Vision
EYE
Mkt Cap1.53B
National Vision Holdings, Inc. operates in the eye care retail sector, providing eyewear and services that, while not direct pharmaceuticals, compete in the broader eye care market.
Cooper Companies
COO
Mkt Cap14.86B
The Cooper Companies operate in the medical device sector, focusing on contact lens and women's health, and compete in the eye care market with Harrow through their vision products.
Staar Surgical
STAA
Mkt Cap1.31B
STAAR Surgical Company specializes in implantable lenses and related products for the eye, competing with Harrow in providing solutions for vision correction.

About

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
Show more...
CEO
Mark L. Baum
Employees
373
Country
United States
ISIN
US4158581094
WKN
000A2PBJD

Listings

XNAS
US
HROW
F
DE
3IP.F
STU
DE
3IP.STU
BOATS
BOATS
HROW.BOATS

0 Comments

Share your thoughts

FAQ

What is Harrow stock price today?▼
The current price of HROW is $40.95 USD — it has decreased by -2.64% in the past 24 hours. Watch Harrow stock price performance more closely on the chart.
What is Harrow stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Harrow stocks are traded under the ticker HROW.
Is Harrow stock price growing?▼
HROW stock has risen by +2.3% compared to the previous week, the month change is a -4.39% fall, over the last year Harrow has showed a +4.68% increase.
What is Harrow market cap?▼
Today Harrow has the market capitalization of 1.54B
When is the next Harrow earnings date?▼
Harrow is going to release the next earnings report on November 16, 2026.
What were Harrow earnings last quarter?▼
HROW earnings for the last quarter are -0.46 USD per share, whereas the estimation was -0.18 USD resulting in a -157.34% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Harrow revenue for the last year?▼
Harrow revenue for the last year amounts to 272.3M USD.
What is Harrow net income for the last year?▼
HROW net income for the last year is -5.14M USD.
How many employees does Harrow have?▼
As of August 22, 2026, the company has 373 employees.
In which sector is Harrow located?▼
Harrow operates in the Health & Wellness sector.
When did Harrow complete a stock split?▼
The last stock split for Harrow was on February 08, 2013 with a ratio of 1:5.
Where is Harrow headquartered?▼
Harrow is headquartered in NASHVILLE, United States.